Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
118 studies found for:    "hereditary hypophosphatemic rickets" OR "Rickets"
Show Display Options
Rank Status Study
1 Enrolling by invitation Calcimimetics in Hypophosphatemic Rickets
Condition: Familial Hypophosphatemic Rickets
Intervention: Drug: Cinacalcet
2 Recruiting Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.
Condition: Autosomal Dominant Hypophosphatemic Rickets
Intervention: Dietary Supplement: Iron
3 Unknown  Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
Condition: Hypophosphatemic Rickets, X-Linked Dominant
Intervention: Drug: Cinacalcet
4 Completed Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
Condition: Primary Hypophosphatemic Rickets
Intervention: Drug: Z-521
5 Completed A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
Condition: X-linked Hypophosphatemic Rickets/Osteomalacia
Intervention: Drug: KRN23
6 Completed Growth Hormone Treatment in Children With Hypophosphatemic Rickets
Condition: X Linked Hypophosphatemic Rickets
Intervention: Drug: norditropine simplex
7 Unknown  Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
Conditions: Hypophosphatemic Rickets;   Growth Disorders;   Somatropin Therapy
Intervention: Drug: somatropin
8 Completed Calcitonin for Treating X-linked Hypophosphatemia
Condition: Hypophosphatemic Rickets, X Linked Dominant
Interventions: Drug: nasal salmon calcitonin;   Drug: Saline Nasal Spray Placebo
9 Completed Study to Assess the Use of a Simple Lab Test to Screen for Rickets in Children
Condition: Rickets
Intervention:
10 Completed Role of Calcium And Vitamin D In Nutritional Rickets And It's Management
Condition: Nutritional Rickets
Interventions: Drug: Vitamin D;   Drug: Calcium Carbonate;   Drug: Vitamin D and Calcium
11 Completed Vitamin D and Genetics in Nutritional Rickets
Condition: Nutritional Rickets
Interventions: Dietary Supplement: Vitamin D + Calcium;   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D2;   Dietary Supplement: Vitamin D3
12 Active, not recruiting Hypophosphatemic Rickets in Norway
Conditions: Hypophosphatemia, Familial;   Rickets;   Hyperphosphatemia
Interventions: Dietary Supplement: Alfacalcidol; phosphate.;   Drug: Sevelamer
13 Completed A Study of KRN23 in X-linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Interventions: Drug: Placebo;   Drug: KRN23
14 Completed A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23
15 Completed An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23
16 Enrolling by invitation Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Intervention: Drug: KRN23
17 Active, not recruiting Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Interventions: Biological: KRN23;   Other: Placebo
18 Active, not recruiting Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23
19 Active, not recruiting Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Intervention: Drug: KRN23
20 Recruiting Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Interventions: Biological: KRN23;   Drug: Oral Phosphate;   Drug: Active Vitamin D

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.